Weight Loss Injections UK: Your Complete Guide to Mounjaro, Wegovy and Ozempic

Weight loss injections UK patients are increasingly turning to have transformed the approach to managing obesity. With 1.6 million adults in England, Wales and Scotland using medications like Mounjaro and Wegovy in the past year alone, these treatments represent a significant shift in how we address weight-related health conditions. At Abbey Wood Hospital’s GP Services, we provide comprehensive weight management support that combines prescription medication with expert dietitian guidance for lasting results.

This guide explains how these medications work, compares the different options available, and helps you understand whether weight loss injections UK treatment might be suitable for your circumstances.

How Weight Loss Injections Work

Weight loss injections belong to a class of medications called GLP-1 receptor agonists. They work by mimicking a hormone called glucagon-like peptide-1 that your body naturally releases after eating. This hormone signals to your brain that you feel full, reduces appetite and slows down how quickly food moves through your digestive system.

According to NHS England, these medications make you feel fuller for longer and therefore less hungry. The result is that you naturally eat smaller portions and feel satisfied with less food, leading to gradual and sustainable weight loss when combined with lifestyle changes.

Mounjaro (tirzepatide) works slightly differently by targeting two hormones rather than one. It mimics both GLP-1 and another hormone called GIP (glucose-dependent insulinotropic polypeptide), which may explain why clinical trials show it produces greater weight loss compared to single-hormone medications. Research published in the New England Journal of Medicine found participants taking Mounjaro lost an average of 20.2 per cent of their body weight over 72 weeks, compared to 13.7 per cent for those taking Wegovy.

Comparing Mounjaro, Wegovy and Ozempic

Understanding the differences between these medications helps you make informed decisions about which weight loss injections UK treatment might suit your needs.

Mounjaro (Tirzepatide)

Mounjaro is the newest weight loss injection available in the UK and has shown the most significant results in clinical trials. It targets two hormones (GLP-1 and GIP) and is administered as a weekly injection. Clinical data suggests weight loss of up to 22 per cent of body weight over 72 weeks. Mounjaro is now available on the NHS for eligible patients and through private prescription for those who do not meet NHS criteria.

Wegovy (Semaglutide)

Wegovy contains semaglutide and is specifically licensed for weight management. It works by mimicking GLP-1 alone and typically produces weight loss of 15 to 17 per cent over 68 weeks. Wegovy is available through NHS specialist weight management services and private prescription. According to the British Heart Foundation, research shows semaglutide can also reduce the risk of heart attack and stroke by 20 per cent in people with existing cardiovascular disease.

Ozempic (Semaglutide)

Ozempic contains the same active ingredient as Wegovy but is licensed only for type 2 diabetes management, not weight loss. While weight loss occurs as a side effect, using Ozempic specifically for weight management is considered off-label use. If your primary goal is weight loss rather than diabetes management, Wegovy or Mounjaro would be more appropriate options.

NHS Eligibility and Access

NHS access to weight loss injections UK follows strict eligibility criteria, with a phased rollout prioritising those with the greatest clinical need. Understanding these requirements helps you determine whether NHS treatment is an option for you.

According to NICE guidance TA1026, Mounjaro is recommended for adults with a BMI of at least 35 kg/m² (or 32.5 kg/m² for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds) who also have at least one weight-related health condition.

However, due to capacity limitations, the current NHS rollout further restricts initial access. During the first phase (2025/26), patients must have a BMI of 40 or more and at least four of the following conditions: type 2 diabetes, high blood pressure (hypertension), high cholesterol (dyslipidaemia), established cardiovascular disease and obstructive sleep apnoea.

Wegovy is available through NHS specialist weight management services for patients with a BMI of 35 or more (or 32.5 for certain ethnic backgrounds) who have at least one weight-related comorbidity. Treatment duration on the NHS is typically limited to two years.

For many people, these criteria present significant barriers to accessing treatment. Research from King’s College London warns that strict NHS eligibility rules risk creating a two-tier system where financial means play a major role in who receives care. This is particularly concerning given that 3.3 million additional people have expressed interest in using weight loss medications.

Private Treatment Options

Private treatment offers an alternative pathway for those who do not meet NHS criteria or prefer not to wait for NHS services to become available in their area. Our Weight Management Clinic provides comprehensive assessment and treatment for eligible patients.

Private eligibility criteria are typically less restrictive than NHS requirements. Most private providers require patients to be aged 18 or over with a BMI of 30 or above, or 27 or above with weight-related health issues such as high blood pressure, type 2 diabetes or high cholesterol.

The key advantage of private treatment is access to a holistic approach that addresses the underlying factors contributing to weight gain. At Abbey Wood Hospital, our weight management service combines prescription medication with expert support from Heather Daniels, our specialist dietitian, who provides personalised nutritional guidance alongside your medical treatment.

Private costs for weight loss injections UK vary depending on the medication and dosage. Wegovy typically costs between £179 and £295 per month, while Mounjaro ranges from approximately £149 for starting doses to £375 for maintenance doses. These costs reflect the medication itself and should be considered alongside consultation fees and ongoing support.

What to Expect from Treatment

Starting weight loss injections involves a gradual process of dose escalation to minimise side effects and allow your body to adjust to the medication. Treatment typically begins with a low dose that increases every four weeks until you reach your maintenance dose.

Most patients notice reduced appetite and increased feelings of fullness within the first few weeks. However, significant weight loss usually becomes apparent after two to three months of treatment. Clinical trials show that maximum weight loss typically occurs between 12 and 18 months of consistent use.

For treatment to be effective, weight loss injections UK guidance emphasises the importance of combining medication with lifestyle changes. This is why NHS prescriptions require participation in “wraparound care” programmes focusing on diet and physical activity. Our dietitian services provide this essential support, helping you develop sustainable eating habits that maintain your results long-term.

If you have struggled with weight loss in the past, particularly weight loss after 40, these medications can provide the metabolic support needed to break through plateaus. However, they work best as part of a comprehensive approach rather than a standalone solution.

Side Effects and Safety

Like all medications, weight loss injections can cause side effects. The most common are gastrointestinal symptoms including nausea, vomiting, diarrhoea, constipation and stomach discomfort. According to patient information leaflets, these affect approximately 1 in 10 people and are usually most pronounced during the dose escalation phase before improving as your body adjusts.

Other reported side effects include tiredness, dizziness, hair loss and a fast heart rate. Less commonly, some people experience low blood sugar (particularly if also taking diabetes medications) or gallbladder problems. The MHRA Yellow Card scheme monitors ongoing safety and encourages reporting of any suspected adverse reactions.

Tirzepatide (Mounjaro) is currently classified as a Black Triangle medication, meaning it is subject to additional safety monitoring. This is standard practice for newer medications and does not indicate safety concerns beyond the need for ongoing data collection.

Important Contraindications

Weight loss injections are not suitable for everyone. You should not use these medications if you are pregnant, planning to become pregnant or breastfeeding. Semaglutide should be stopped at least two months before pregnancy, and tirzepatide at least one month before.

If you take the oral contraceptive pill, Mounjaro may reduce its effectiveness. You should use additional contraception such as condoms or consider switching to non-oral methods like a coil or implant. Similarly, oral HRT may be less effective, so patches or gels absorbed through the skin are recommended.

Before any surgical procedure, inform your healthcare team that you are taking weight loss medication, as this affects anaesthetic considerations.

Why a Holistic Approach Matters

Weight loss injections UK patients achieve the best results when medication forms part of a comprehensive weight management strategy. Research shows that people who stop taking these medications without established lifestyle changes regain approximately 66 per cent of their lost weight within one year.

This is why our approach at Abbey Wood Hospital combines weight loss medication with expert dietitian support. Heather Daniels works alongside our prescribing clinicians to develop personalised nutrition plans that address your individual needs, preferences and lifestyle factors.

A holistic approach considers not just what you eat but why you eat, addressing emotional eating patterns, practical barriers to healthy eating and sustainable strategies for long-term weight maintenance. This combination of medical treatment and behavioural support gives you the best chance of maintaining your results after completing medication.

Frequently Asked Questions

How quickly will I lose weight on Mounjaro or Wegovy?

Most people notice reduced appetite within the first few weeks, with visible weight loss typically becoming apparent after two to three months. Maximum weight loss usually occurs between 12 and 18 months of consistent treatment combined with lifestyle changes.

Can I get weight loss injections from my GP?

Currently, GP prescribing of Mounjaro is limited to patients meeting strict NHS criteria (BMI 40+ with four specified comorbidities). Wegovy requires referral to specialist weight management services. Private treatment offers an alternative pathway for those who do not meet NHS eligibility requirements.

What happens when I stop taking weight loss injections?

Research shows that without established lifestyle changes, people typically regain around two-thirds of lost weight within a year of stopping medication. This is why combining treatment with dietitian support and sustainable lifestyle modifications is essential for maintaining results.

Are weight loss injections safe for long-term use?

Current evidence supports the safety of these medications for extended use, though ongoing monitoring continues. NICE guidance recommends annual reviews to assess whether continuing treatment remains appropriate based on individual progress and health status.

How do I know if weight loss injections are right for me?

A consultation with a healthcare professional can assess your suitability based on your BMI, health conditions, medical history and weight loss goals. This assessment ensures you receive appropriate treatment and identifies any contraindications that might affect your care.


Start Your Weight Management Journey

If you are considering weight loss injections UK treatment, professional guidance ensures you receive safe and effective care tailored to your individual needs. Our Weight Management Clinic combines prescription medication with expert support from Heather Daniels, our specialist dietitian, providing the holistic approach that research shows delivers the best long-term results.

Book your weight management consultation at Abbey Wood Hospital, Page Street, Mill Hill, London NW7 2ED. We are open 8am to 8pm Monday to Friday and 9am to 6pm at weekends. Call 020 8358 7100 or book an appointment online.

This article provides general health information and does not constitute medical advice. Weight loss medications are prescription-only and require assessment by a qualified healthcare professional to determine suitability for your individual circumstances.